The World Health Organization (WHO) estimates that asthma affected 262 million people worldwide in 2019 and caused 455,000 deaths that year. It is one of the most common chronic diseases on the planet, affecting children and adults on every continent. Most asthma-related deaths occur in low- and lower-middle-income countries, where people often lack access to proper diagnosis and affordable medication.
What Asthma Does to the Airways
Asthma is a chronic condition in which the airways become inflamed, narrow, and produce excess mucus. This makes breathing difficult and triggers recurring episodes of wheezing, chest tightness, shortness of breath, and coughing. These episodes can range from mild annoyances to life-threatening emergencies. The airways of someone with asthma are persistently inflamed even between flare-ups, which is why ongoing treatment matters rather than only treating symptoms when they appear.
Symptoms often worsen at night or early in the morning. Physical activity, cold air, respiratory infections, and exposure to allergens or pollutants can all set off an episode. The pattern and severity vary widely from person to person. Some people experience symptoms only a few times a year, while others deal with daily limitations.
Major Risk Factors and Triggers
Asthma results from a mix of genetic predisposition and environmental exposures. People with a family history of asthma or allergies are more likely to develop the condition. Specific genetic variants interact with environmental factors in complex ways. For example, children born to mothers who smoked during pregnancy carry a higher risk, particularly if they also have certain gene variants on chromosome 17.
Indoor allergens are among the most important triggers. Dust mites are the most prevalent and most studied indoor allergen linked to asthma. Cockroach allergens have been established as a significant cause of asthma flare-ups for decades. Cat and dog dander is associated with more severe asthma in childhood. Mold species found both indoors and outdoors contribute as well, with common culprits including types that thrive in damp indoor environments and others that flourish outside in warmer months. Mouse allergens, once thought to be mainly an occupational hazard for lab workers, are now recognized as a meaningful trigger in homes, particularly in urban settings.
Air pollution plays a major role. Particulate matter, nitrogen dioxide, sulfur dioxide, and ozone all worsen asthma. Even short-term exposure to these pollutants can increase symptoms in children. Nitrogen dioxide from gas stoves and other indoor combustion sources adds to the indoor pollution burden alongside the outdoor environment.
A Global Problem of Misdiagnosis
One of the more striking facts about asthma is how frequently it is both overdiagnosed and underdiagnosed. Overdiagnosis means people take daily medication for a condition they may not have, while underdiagnosis means others live with preventable symptoms and risk serious complications including permanent airway damage.
A major Canadian study re-examined 613 adults who had been diagnosed with asthma. After thorough testing, asthma was ruled out in 33% of them, and after 12 months, 30% remained off asthma medication with no problems. A similar UK study found that one-third of patients labeled with asthma had completely normal lung function tests. Among people with severe obesity being screened before weight-loss surgery, 40% of those with a prior asthma diagnosis did not actually meet the diagnostic criteria on proper testing.
Underdiagnosis is equally widespread. Estimates range from 19% to 73% of cases being missed, depending on the population studied. In a large Copenhagen study involving over 10,000 people, researchers identified 493 individuals with definite asthma, and half of them had never been diagnosed. Studies in Italy found about 32% of people with confirmed asthma had no previous diagnosis. In the United States, 30% of young adults entering military service who tested positive for asthma had never had the diagnosis considered. Even among older adults with no significant smoking history, roughly 15% of those without a physician diagnosis had symptoms consistent with asthma.
This pattern of misdiagnosis is not limited to any one country. It reflects a global challenge: asthma symptoms overlap with many other conditions, and proper diagnosis requires lung function testing that is not always available or performed.
How the WHO Classifies Asthma Treatment
The WHO includes asthma medications on its Model List of Essential Medicines, a catalogue of the most important drugs that should be available in every health system worldwide. The core asthma treatment on this list is a combination inhaler containing two types of medication: one that reduces airway inflammation and one that relaxes the muscles around the airways to open them up. Several therapeutic alternatives using different drug combinations are also listed, giving countries flexibility based on what they can source and afford.
The principle behind modern asthma management is that most people need a daily controller medication to keep inflammation down, not just a rescue inhaler for emergencies. When asthma is well controlled, people can exercise normally, sleep through the night, and avoid emergency visits. The gap between this ideal and reality is enormous in many parts of the world. In low-income countries, inhalers may be unavailable, unaffordable, or unfamiliar to both patients and healthcare providers. This is the primary reason that most asthma deaths occur in lower-income settings, not because the disease itself is more severe there.
Why Deaths Are Concentrated in Poorer Countries
The 455,000 annual deaths from asthma are not distributed evenly. The WHO emphasizes that the vast majority occur in low- and lower-middle-income countries. The core issue is a cycle of under-diagnosis and under-treatment. Without proper diagnosis, people never receive controller medications. Without controller medications, chronic inflammation worsens over time, airways remodel and stiffen, and acute attacks become more dangerous. When severe attacks do happen, emergency care may be hours away or simply unavailable.
Even in wealthier countries, disparities exist. Urban communities with higher levels of indoor allergens (cockroach and mouse allergens, mold from poor housing conditions) and outdoor air pollution bear a disproportionate burden. Children in these environments develop asthma at higher rates and experience more frequent, more severe episodes. The environmental and economic dimensions of asthma make it as much a public health equity issue as a clinical one.
Living With Asthma
For most people, asthma is a manageable condition. With the right medication and trigger avoidance, the majority of those affected can live without significant limitations. Key practical steps include identifying your specific triggers, using controller medication consistently rather than only during flare-ups, keeping a rescue inhaler accessible, and having a written action plan that spells out what to do when symptoms escalate.
Reducing indoor allergen exposure makes a measurable difference. This means addressing moisture problems that promote mold, using allergen-proof mattress and pillow covers to limit dust mite contact, and managing pest issues in the home. For outdoor air pollution, staying indoors during high-pollution days and keeping windows closed can help, though these are stopgap measures rather than solutions to the underlying environmental problem. Asthma cannot be cured, but with proper management, it does not have to limit daily life.